Lower Survival With Checkpoint Inhibitors in Bladder Cancer Lower Survival With Checkpoint Inhibitors in Bladder Cancer
Agencies in both the United States and Europe have warned about a decreased survival in patients treated with checkpoint inhibitors compared with those receiving chemotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Health | Hematology | USA Health